Biohaven Ltd. (BHVN) stock
BHVNNYSEPharmaceutical PreparationsFiscal year ends December 31
$13.24−0.56 (-4.06%)
Close on Nov 17, 2026Market cap $2.00BP/E –Yield –
Biohaven total assets
Total assets on the balance sheet at the end of each period.
Biohaven's total assets was $263.68M at Sep 30, 2026. For fiscal 2025 it was $451.45M, down 26.6% from the year before. The highest annual figure on record is $661.78M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $451.45M | -26.6% |
| FY2024 | Dec 31, 2024 | $615.11M | +19.9% |
| FY2023 | Dec 31, 2023 | $513.21M | -22.5% |
| FY2022 | Dec 31, 2022 | $661.78M | +365.8% |
| FY2021 | Dec 31, 2021 | $142.06M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $263.68M | -35.6% |
| Q2 FY2026 | Jun 30, 2026 | $370.74M | -32.6% |
| Q1 FY2026 | Mar 31, 2026 | $466.41M | +1.6% |
| Q4 FY2025 | Dec 31, 2025 | $451.45M | -26.6% |
| Q3 FY2025 | Sep 30, 2025 | $409.12M | -19.9% |
| Q2 FY2025 | Jun 30, 2025 | $550.42M | -5.5% |
| Q1 FY2025 | Mar 31, 2025 | $458.95M | +9.7% |
| Q4 FY2024 | Dec 31, 2024 | $615.11M | +19.9% |
| Q3 FY2024 | Sep 30, 2024 | $510.52M | +33.4% |
| Q2 FY2024 | Jun 30, 2024 | $582.64M | +15.0% |
| Q1 FY2024 | Mar 31, 2024 | $418.53M | -32.3% |
| Q4 FY2023 | Dec 31, 2023 | $513.21M | -22.5% |
| Q3 FY2023 | Sep 30, 2023 | $382.74M | +182.2% |
| Q2 FY2023 | Jun 30, 2023 | $506.74M | +256.7% |
| Q1 FY2023 | Mar 31, 2023 | $618.52M | – |
| Q4 FY2022 | Dec 31, 2022 | $661.78M | – |
| Q3 FY2022 | Sep 30, 2022 | $135.65M | – |
| Q4 FY2021 | Dec 31, 2021 | $142.06M | – |
See a number that looks wrong?